RealFeedApp Fractyl's Revita undergoes a six-month pivotal trial
The Revita trial demonstrated that remodeling the duodenal lining helps maintain weight loss after stopping GLP-1 medications.
- Field
- ageing and longevity
- What they did
- Fractyl Health conducted a pivotal trial (REMAIN-1) showing that the Revita procedure, which remodels the lining of the duodenum, helped participants maintain weight after stopping GLP-1 drugs.
- Why it matters
- This could be useful for people who regain weight after discontinuing obesity medications, as the procedure aims to restore intestinal function that may be disrupted by chronic metabolic disease.
#glp-1#weight loss#duodenum#fractyl#revita
